ENDOCRINE SOCIETY
OXFORD
Correction to: Response to Letter to the Editor from de Ponthaud et al: “Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival”
The above Letter to the Editor Response by Srougi V, Habra MA, and Fragoso MCBV (J Clin Endo Metab. 2022; doi: 10.1210/clinem/dgac097), first appeared in Corrected Proof form as a Letter to the Editor, owing to a production error. The item should have appeared as a Letter to the Editor Response.
The title was first published as “Response Letter to the Editor from de Ponthaud et al: “Cytoreductive Surgery of
the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival."" The correct title is ""Response to Letter to the Editor from de Ponthaud et al: “Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival.""
The errors have been corrected online. doi.org/10.1210/clinem/dgac097